Rewriting the story of disease

Genetic predisposition shouldn’t dictate your health destiny. We’re committed to unlocking the future of medicine by engineering CRISPR-based therapeutics safe and effective enough to transform everyone's lifetime risk for disease.

If we could blueprint the future of medicine, what would it look like?

Preventative

You could prevent common diseases by calibrating your genome.

Liberating

You could unshackle yourself from inherited conditions, predispositions, and lifetime treatment.

Universal

Genetic medicines would be safe and accessible for everyone – beyond rare diseases.

CrISPR By Design

This future is only possible with CRISPR genetic medicines precisely engineered for safety and potency

Engineering by Design

CRISPR medicine shouldn’t take shortcuts. Our comprehensive molecular engineering approach takes small, iterative, and intentional steps to develop CRISPR systems safe and specific enough to help millions of people.

Platform

Portfolio by Design

We’ve engineered purpose-built CRISPR-based therapeutics to have the broadest possible impact, starting with the leading cause of death globally — cardiometabolic disease.

Pipeline
We’re dedicated to making CRISPR safe and effective enough for widespread use. We envision a world in which we all take control of our own health destiny – not just inherit it.

Benjamin Oakes

Scribe, Founder & CEO

Partners

We are broadening our molecular engineering approach to other therapeutic areas through strategic collaborations with world-leading pharmaceutical companies.

Work with us
Sanofi

Ex Vivo NK Cell Therapies for Oncology

SCD & Other Genetic Disease

LearN More
Prevail Therapeutics | A wholly owned subsidiary of Eli Lilly and CompanyLilly

Neuromuscular & Neurologic Disease

LearN More